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se,BACKGROUND AND PURPOSE
The TRPC5 proteins assemble to create calcium-permeable, non-selective, cationic channels. We sought novel modulators of
these channels through studies of natural products.
EXPERIMENTAL APPROACH
Intracellular calcium measurements and patch clamp recordings were made from cell lines. Compounds were generated by
synthetic chemistry.
KEY RESULTS
Through a screen of natural products used in traditional Chinese medicines, the ﬂavonol galangin was identiﬁed as an inhibitor of
lanthanide-evoked calcium entry in TRPC5 overexpressing HEK 293 cells (IC50 0.45 μM). Galangin also inhibited lanthanide-
evoked TRPC5-mediated current in whole-cell and outside-out patch recordings. In differentiated 3T3-L1 cells, it inhibited con-
stitutive and lanthanide-evoked calcium entry through endogenous TRPC5-containing channels. The related natural ﬂavonols,
kaempferol and quercetin were less potent inhibitors of TRPC5. Myricetin and luteolin lacked effect, and apigenin was a stimu-
lator. Based on structure–activity relationship studies with natural and synthetic ﬂavonols, we designed 3,5,7-trihydroxy-2-
(2-bromophenyl)-4H-chromen-4-one (AM12), which inhibited lanthanide-evoked TRPC5 activity with an IC50 of 0.28 μM. AM12
also inhibited TRPC5 activity evoked by the agonist ()-Englerin A and was effective in excised outside-out membrane patches,
suggesting a relatively direct effect. It inhibited TRPC4 channels similarly, but its inhibitory effect on TRPC1–TRPC5 heteromeric
channels was weaker.
CONCLUSIONS AND IMPLICATIONS
The data suggest that galangin (a natural product from the ginger family) is a TRPC5 inhibitor and that other natural and synthetic
ﬂavonoids contain antagonist or agonist capabilities at TRPC5 and closely related channels depending on the substitution
patterns of both the chromone core and the phenyl ring.Abbreviations
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on behalf of British Pharmacological Society.
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In mammals, twenty-eight genes encode transient receptor
potential (TRP) proteins (Damann et al., 2008). These
proteins assemble to form homotetrameric or hetero-
tetrameric cationic channels, which are most commonly
localized to the plasma membrane. Although there are
similarities between different TRPs, they are diverse in
sequence and the assembled channels are differentially
activated or inhibited by physico-chemical signals, including
hot and cold temperatures and a plethora of chemicals,
some of which are natural products such as capsaicin and
menthol (Vriens et al., 2008). Several of the TRP channels
have attracted attention as potential targets for drug
discovery efforts, for example, TRPV1 or TRPA1 in the
analgesia ﬁeld.
The C subfamily of TRPs has seven members, TRPC1–7,
although one of them, TRPC2, is not expressed in humans
(Abramowitz and Birnbaumer, 2009; Beech, 2013; Birnbaumer,
2009; Bon and Beech, 2013). The TRPC subfamily is the one
that is most closely related to the ﬁrst-identiﬁed TRP of
photo-transduction in Drosophila melanogaster: hence C, for
canonical. The properties of the TRPCs have been reviewed
(Abramowitz and Birnbaumer, 2009; Beech, 2013;
Birnbaumer, 2009; Bon and Beech, 2013). Here, we focused
on transient receptor potential canonical 5 (TRPC5), which,
like most other TRPCs, assembles as homotetramers to form
non-selective Ca2+-permeable cationic TRPC5 channels, but
it also heteromerizes with other TRPCs such as transient
receptor potential canonical 1 (TRPC1) (Beech, 2007;
Zholos, 2014). TRPC5 is often noted for its expression in
the CNS and is sometimes indicated as being exclusively
neuronal. In this context, innate fear and pro-epileptic
roles have been suggested for TRPC5 as well as roles in
growth cone formation and other neuronal functions
(Greka et al., 2003; Phelan et al., 2013; Riccio et al., 2009).
TRPC5 is, nevertheless, also expressed in peripheral tissues
where non-neuronal roles have been suggested, such as in
podocyte barrier function, cancer cell multidrug resistance
and adiponectin secretion from adipocytes (Ma et al.,
2014; Schaldecker et al., 2013; Sukumar et al., 2012). TRPC5
channels can exhibit constitutive activity but are alsomodestly or strongly stimulated by various externally ap-
plied factors that are not speciﬁc to TRPC5 but include
lanthanide ions (Gd3+ and La3+), sphingosine-1-phosphate
(S1P) and lysophosphatidylcholine (LPC) (Flemming
et al., 2006; Jung et al., 2003; Xu et al., 2006; Zeng et al.,
2004). Lanthanides appear to act as direct activators or
facilitators of channel opening, whereas S1P acts indirectly
via G protein signalling (Jung et al., 2003; Xu et al., 2006).
There is a view that TRPC5 forms a receptor-activated
channel and that this is its physiological purpose, but
there is also the view that it is activated by stress factors
without the need for receptor activation (Birnbaumer,
2009; Jiang et al., 2011). Both may be true and, indeed,
TRPC5 channels, like several other TRP channels, show
what is variously described as versatility, promiscuity or
multiplicity of activation (Birnbaumer, 2009; Jiang et al.,
2011; Vriens et al., 2008; Zeng et al., 2004).
As with other members of the TRPC subfamily, the
pharmacology of low MW ligands for TRPC5 channels is
relatively underdeveloped, often lacking potency and
speciﬁcity and often not acting directly; various modulators
of this type have been reviewed (Bon and Beech, 2013; Jiang
et al., 2011). There is emerging evidence for synthetic low
MW modulators, which include sigma-1 receptor ligands,
the antihistamine clemizole hydrochloride, riluzole, the
2-aminoquinoline ML204 and the 2-aminobenzimidazole
derivative M084 (Amer et al., 2013; Miller et al., 2011;
Richter et al., 2014a; Richter et al., 2014b; Zhu et al.,
2015). There is also evidence for antagonist capability in
dietary substances that include ω-3 fatty acids and
antioxidant chemicals, such as vitamin C, gallic acid and
the polyphenol resveratrol (Naylor et al., 2011; Sukumar
et al., 2012). Conversely, a remarkably potent and selective
activator exists in ()-Englerin A, which derives from
the plant Phyllanthus engleri (Akbulut et al., 2015). Such
sensitivity to natural products aligns with the ﬁndings for
other TRP subfamilies and a general concept for TRP
channels as integrators of animal biology with physical
factors of the external environment (Vriens et al., 2008).
Here, we sought new information on TRPC5 channel
modulators by testing a small set of natural products from
traditional Chinese medicines.British Journal of Pharmacology (2016) 173 562–574 563
BJP J Naylor et al.Methods
Plasmids for TRPC1/TRPC5 and HEK-TRPC3
experiments
Human TRPC3 was cloned into the pcDNA™4/TO expression
vector (ThermoFisher Scientiﬁc, Waltham, MA, USA) between
KpnI and XbaI restriction sites using hTRPC3/pcDNA3 (from
M Zhu, Ohio State University) as a PCR template (forward primer:
5′ CAGTGGTACCGCCACCATGGAGGGAAGCCCATC 3′,
and reverse primer: 5’ ACACTCTAGATCATTCACATCTC
AGCATGCTG 3′). To facilitate cloning of SYFP2–TRPC1 and
mTurquoise2–TRPC5, a four amino acid linker (ASAS) ﬂanked
by AgeI and SacII restriction sites was introduced into
pcDNA™4/TO between EcoRI and XhoI restriction sites using
Gibson Assembly® (New England Biolabs, Ipswich, MA, USA)
(forward oligonucleotide: 5′ CCACTAGTCCAGTGTGGTGGA
ATTCACCGGTGCCAGCGCATCCCGC 3′, and reverse oligonu-
cleotide: 5′ GTTTAAACGGGCCCTCTAGACTCGAGCCGC
GGGATGCGCTGGCACC 3′). Fluorophores were inserted
upstream of the linker between KpnI and AgeI restriction sites
using pSYFP2-C1 (Addgene plasmid # 22878; Kremers et al.,
2006) and pmTurquoise2-C1 (Addgene plasmid # 60560;
Goedhart et al., 2010), gifts from Dorus Gadella, as PCR
templates (mTurquoise2/SYFP2 forward primer: 5′ TAATGGTA
CCGCCACCATGGTGAGC 3′, and mTurquoise2/SYFP2 reverse
primer: 5′ TATTACCGGTCTTGTACAGCTCGTCCATGC 3′).
Human TRPC1 (forward primer: 5′ ACTTCCGCGGCATG
ATGGCGGCCCTG 3′, and reverse primer: 5′ TTGCTCTA
GAAAATGGTTAATTTCTTGGATAAAAC 3′) or human TRPC5
(forward primer: 5′ GATCCCGCGGAATGGCCCAACTGTACT
ACAAAAAG 3′, and reverse primer: 5′ GGGTCAAGGAAGG
CACG3′)was inserted downstream of the linker between SacII
and XbaI restriction sites using hTRPC1/pIRES (Xu et al., 2006)
and hTRPC5/pcDNA™4/TO (Zeng et al., 2004) as PCR templates.
All constructs contained an N-terminal Kozak sequence.
Cell culture
HEK 293 cells stably expressing tetracycline-regulated human
TRPC5 (Zeng et al., 2004) or TRPC4 (Akbulut et al., 2015)
have been described. An equivalent cell line expressing
TRPC3 was established. Cells were maintained in DMEM-
F12 + GlutaMAX-1 (ThermoFisher Scientiﬁc) supplemented
with 10% fetal calf serum (FCS) and penicillin/streptomycin
at 37 °C in a 5% CO2 incubator. For selection, 400 μg·mL
1
zeocin and 5 μg·mL1 blasticidin S were included in the cell
medium. To induce expression, cells were incubated
with 1 μg·mL1 tetracycline (Sigma-Aldrich, Gillingham,
UK) for 24 h prior to experiments (Tet+). Non-induced cells
without addition of tetracycline (Tet) were used as control.
HEK 293 cells stably expressing tetracycline-regulated human
TRPM2 were prepared similarly and have also been described
previously (McHugh et al., 2003). TRPV4 was studied in CHO
K1 cells stably expressing human TRPV4 and maintained
in Ham’s F12 (ThermoFisher Scientiﬁc) in the presence
of 1 mg·mL1 G418 (Sigma-Aldrich).
The 3T3-L1 cell line was obtained from the American
Type Culture Collection and cultured in DMEM-F12 con-
taining 10% fetal calf serum (FCS), 100 U·mL1 penicillin
and 100 μg·mL1 streptomycin. To induce differentiation,
cells were grown to conﬂuence, and 2 days post-conﬂuence,564 British Journal of Pharmacology (2016) 173 562–574the medium was changed to a medium containing 5 μg·mL1
insulin, 0.25 μM dexamethasone and 0.5 mM IBMX with
10% FCS and antibiotics. After 48 h, medium was changed
to a maintenance medium containing 5 μg·mL1 insulin,
10% FCS and antibiotics. Cells were fed with fresh mainte-
nance medium every 2 days until the day of experiments.
For all experiments, cells were differentiated for 12–16 days.Intracellular Ca2+ measurement
Induced (Tet+) and non-induced (Tet) cells were plated in
poly-d-lysine-coated black 96-well plates (Corning, Corning,
NY, USA) at a conﬂuence of 90% 24 h before experimentation.
Cells were incubated for 1 h in 4 μM ﬂuo-4-AM, 2 μM
fura-2-AM or 4 μM XRhod-1-AM in standard bath solution
(SBS) at 37 °C in the presence of 0.01% pluronic acid
(ThermoFisher Scientiﬁc) and, for ﬂuo-4-AM and XRhod-1-AM,
2.5 mM probenecid. SBS contained (mM) the following: 130
NaCl, 5 KCl, 8 d-glucose, 10 HEPES, 1.2 MgCl2 and 1.5 CaCl2;
the pH was titrated to 7.4 with NaOH, and the osmolarity was
~290 mOsm. Cells were washed three times with SBS before
measurements were made at room temperature (21 ± 2 °C) on a
96-well ﬂuorescence plate reader (FlexStation II384, Molecular
Devices, Sunnyvale, CA, USA). Fura-2 was excited at 340 and
380 nm, and emitted light was collected at 510 nm. Fluo-4 was
excited at 485 nm, and emitted light was collected at 525 nm.
XRhod-1 was excited at 580 nm, and emitted light was collected
at 610 nm. Readings were made every 10 s. Fura-2 measurements
are shown as the ﬂuorescence (F) ratio or change (Δ) in this ratio.
Fluo-4 and XRhod-1 measurements are shown as absolute
ﬂuorescence in arbitrary units or changes in this ﬂuorescence
(ΔF). For experiments requiring no extracellular Ca2+, BaCl2
replaced the CaCl2 in SBS. When required, pretreatments with
ﬂavonoids were for 30 min at room temperature prior to
recordings and maintained throughout. Control cells were
treated with DMSO (vehicle) as appropriate.Electrophysiology
Current recordings were made under voltage clamp using
the whole-cell or outside-out conﬁguration of the patch
clamp technique at room temperature. Cells were seeded
on glass coverslips at 20–30% density. Signals were ampliﬁed
and sampled using an Axopatch 200B ampliﬁer and
pCLAMP 8 or 10 software (Molecular Devices). Data were ﬁl-
tered at 2 kHz and digitally sampled at 4 kHz. The voltage
protocol comprised voltage ramps applied from 100 to
+100 mV or every 10 s from a holding potential of 0 mV.
The extracellular solution was SBS, and the patch pipette
solution contained (mM) the following: 135 CsCl, 2 MgCl2,
1 EGTA, 10 HEPES, 5 Na2ATP and 0.1 Na2GTP, titrated to
pH 7.2 with NaOH. All solutions were ﬁltered using a
0.2 μm ﬁlter (Sartorius, Göttingen, Germany). TRPC4 or
TRPC5 cells were induced by tetracycline 24 h before
experiments. For TRPC1–TRPC5 whole-cell recordings,
HEK 293-MSR cells were transiently transfected with
SYFP2–TRPC1 and mTurquoise2–TRPC5 according to the
manufacturer’s instructions, with the following modiﬁcations:
4.5 μg of each construct and 5.5 μL Lipofectamine®2000
(ThermoFisher Scientiﬁc) were used. Cells were transfected
at 90–95% conﬂuence in a 35 mm culture dish, and
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experiments were performed on the cells 24–48 h post-
transfection.Chemical syntheses
A library of 41 mono-substituted ﬂavonols 4 was prepared
using a two-step synthetic procedure (Scheme S1). The
galangin analogue, 3,5,7-trihydroxy-2-(2-bromophenyl)-4H-
chromen-4-one (AM12) was synthesized in four steps
(Scheme S2). All synthesized chemicals were >97% pure
according to 1H NMR and 13C NMR analyses. Synthetic and
analytical details are reported in the Supporting Information.Chemicals and stock solutions
Commercially available chemicals were purchased from
Sigma-Aldrich, unless stated otherwise. Stocks of chemicals
were reconstituted in an appropriate vehicle: ﬂuo-4-AM,
fura-2-AM and X-Rhod-AM (ThermoFisher Scientiﬁc) were
dissolved at 1 mM in DMSO; pluronic acid F-127 (ThermoFisher
Scientiﬁc) was stored at 10% w/v in DMSO at room temperature;
probenecid was freshly prepared at 0.5 M in 1 M NaOH and
diluted to 1:200 to give a working concentration of 2.5 mM;
galangin, apigenin, kaempferol, quercetin,myricetin and luteolin
were used as 10mMstock solutions in ethanol. All otherﬂavonols
were synthesized and puriﬁed (for details, see the Supporting
Information) and used as 10mM stock solutions in DMSO. Stock
solutions were diluted to 1:1000 into the recording solution,
giving a ﬁnal working concentration of 0.01% solvent. Gd3+
and La3+ were used as aqueous solutions of GdCl3 and LaCl3
respectively. 1-Oleoyl-2-acetyl-sn-glycerol, thapsigargin and
4α-phorbol 12,13-didecanoate were all dissolved in DMSO and
stored as 50, 5 and 10 mM stocks respectively. l-α-LPC from egg
yolk and S1P were dissolved in methanol and stored as stock
concentrations of 5 and 10mM respectively. ATP andH2O2were
stored as aqueous stock solutions. Englerin A was prepared as a
10 mM stock solution in DMSO, stored in aliquots at 80 °C
and diluted to working concentrations in experimental buffer
(e.g. SBS) containing 0.1% DMSO and 0.01% pluronic acid.
Pluronic acid was used as a dispersing agent to minimize
aggregation of Englerin A.Data analysis
Data are presented as mean ± SEM, where n represents the
number of independent experiments and the N represents
the total number of wells of a 96-well plate used for n experi-
ments. For patch clamp experiments, n was the number of
recordings from individual cells. For patch clamp experi-
ments, currents were normalized to the maximum current.
Data subjected to statistical analysis are based on at least ﬁve
individual experiments (n). Data points in individual calcium
imaging experiments were based on at least four replicates
each. Student’s t-tests were used for comparisons between
two sets of data and statistically signiﬁcant differences are
indicated when P < 0.05; no signiﬁcant difference by NS.
For IC50 determinations, data were normalized to the vehicle
controls (DMSO or ethanol), and the Hill equation was ﬁtted
using Origin software (OriginLab, Northampton, MA, USA).Results
Galangin inhibits TRPC5 channels
overexpressed in HEK 293
We screened natural products from traditional Chinesemedicines
for effects on Ca2+ entry in HEK 293 cells overexpressing TRPC5
(Figure S1). Each natural product was pre-incubated with cells
for 30 min and maintained throughout each recording at
10 μM. During the recordings, the lanthanide gadolinium
(50 μM Gd3+) was applied to stimulate the TRPC5-mediated
Ca2+ entry in the presence of each natural product. Through
this screen, galangin was found to be inhibitory against the
Gd3+-evoked signal (Figure 1A). Galangin is from Alpinia
officinarum and other members of the ginger family.
Galangin had a concentration-dependent inhibitory effect
against the Gd3+-evoked Ca2+ signal, acting with an IC50 of
0.45 μM (Figure 1B). It was also effective against Gd3+-evoked
TRPC5-mediated current in whole-cell voltage clamp recordings
(Figure 1C). Its effect occurred within 2 min and was not readily
reversed on washout (Figure 1C). The TRPC5 current–voltage
relationship (I-V) characteristically showed inward rectiﬁcation
at negative voltages and outward rectiﬁcation at positive volt-
ages with a plateau between 0 and +40 mV, which gave an ap-
proximate inverted S-shape and seat-like effect at positive
voltages (Figure 1D). This signature I-V was suppressed by
galangin, consistent with it acting as a TRPC5 channel inhibitor
(Figure 1D). Subsequent application of the TRPC5 inhibitor
2-aminoethoxydiphenylborate (75 μM) (Xu et al., 2005)
further inhibited the current (Figure 1C and D). Galangin was
effective whether Gd3+ activated the channel in the presence
or absence of Ca2+ (Ca2+ was substituted by Ba2+), suggesting
that its action was Ca2+ independent (Figure 1C–E). Galangin
was also effective against TRPC5 current stimulated by S1P,
suggesting that its effect was not restricted to inhibition of the
Gd3+ effect (Figure 1e). Galangin inhibited the TRPC5-mediated
current evoked in excised outside-out membrane patches,
suggesting a relatively direct effect (Figure 1F–H). The data
suggest that galangin is an inhibitor of TRPC5 channels.Galangin inhibits endogenous
TRPC5-containing channels
To determine if galangin also inhibits endogenous channels, we
investigated differentiated 3T3-L1 cells, which are a model of
mature adipocytes and contain Ca2+ signals mediated by
TRPC5-containing channels (Sukumar et al., 2012). These endog-
enous channels exhibit constitutive activity leading to elevated
basal intracellular Ca2+ concentration and further elevation in
response to lanthanum (La3+), another lanthanide ion that was
previously used in place of Gd3+ to activate TRPC5-containing
channels in 3T3-L1 cells (Sukumar et al., 2012; Xu et al., 2008a).
Galangin suppressed the basal Ca2+ signal and the La3+ response
with estimated IC50s of 1.85 and 6.05 μM respectively
(Figure 2A–C). The data suggest that galangin is an inhibitor of
endogenous channels that contain TRPC5.
Diverse effects of different but closely related
natural flavonoids
Galangin is one in a series of compounds found in plants and
commonly in diets and traditional remedies. A screen ofBritish Journal of Pharmacology (2016) 173 562–574 565
Figure 1
Galangin inhibits TRPC5. Recordings were from TRPC5-expressing (Tet+) HEK 293, and extracellular Ca2+ was present at 1.5 mM unless indicated
otherwise. (A) Free intracellular calcium ion (Ca2+i) concentration shown by ﬂuo-4 ﬂuorescence intensity (F) in arbitrary units (AUs). Cells were
incubated with 10 μM galangin or ethanol vehicle control (veh.) for 30 min before 50 μM Gd3+ was applied. (B) As for (A) but concentration–
response data, showing an IC50 of the ﬁtted Hill equation of 0.45 μM (n/N = 5/22). (C) Whole-cell currents obtained during ramp changes in volt-
age from100 to +100 mV every 10 s and during application of 30 μMGd3+ and 10 μMgalangin and then 75 μM2-aminoethoxydiphenylborate
(2-APB) alone. Ba2+ was present in the bath solution rather than Ca2+. (D) Example I-Vs for the experiment in (C). (E) Normalized (norm.) data for
whole-cell currents evoked by 30 μM Gd3+ or 5 μM S1P in the absence () and presence (+) of 10 μM galangin. Ba2+ indicates when Ca2+ was
substituted by barium ions in the bath solution. Currents were normalized to the amplitude prior to galangin application (n = 5, n = 5, n = 5).
(F) Example outside-out patch currents during application of 100 μM Gd3+, 10 μM galangin and 75 μM 2-APB. (G) Example I-Vs for the experi-
ment in (F). (H) Normalized (norm.) data for outside-out patch currents before and after application of 100 μM Gd3+ and after the addition of
10 μM galangin (n = 6). *P < 0.05.
Figure 2
Galangin inhibits Ca2+ entry through endogenous channels in differentiated 3T3-L1 cells. Intracellular Ca2+ was measured using ﬂuo-4. (A)
Example data from a single 96-well plate showing basal Ca2+ and then 20 μM La3+-evoked Ca2+ entry in the presence of vehicle (veh.) and 0.1, 1, 3
and 10 μM galangin. (B, C) Summarized concentration–response data for experiments of the type shown in (A) for (B) basal Ca2+ and (C) La3+-evoked
Ca2+ entry (n/N = 10/59). The IC50s for inhibition of basal and La
3+-evoked Ca2+ entry were 1.85 and 6.05 μM respectively.
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were inhibitors of Gd3+-evoked Ca2+ entry in HEK 293 cells
overexpressing TRPC5 but myricetin, apigenin and luteolin
were not (Figure S2). Although kaempferol and quercetin
were inhibitors, they were less potent than galangin
(Figure 3A and B cf. Figure 1B). Apigenin had a stimulatory
effect in Ca2+ measurement experiments (Figure S2) and was
investigated further by whole-cell voltage clamp recording.
Apigenin was able to stimulate TRPC5-mediated current,
which could then be further enhanced by Gd3+ and blocked
by 2-aminoethoxydiphenylborate (Figure 3C–E). The
apigenin-activated current exhibited the characteristic I-V
shape of TRPC5, suggesting that it is indeed an activator of
TRPC5 channels (Figure 3D). The data suggest that ﬂavonoids
inhibit, stimulate or have no effect on TRPC5 activity
depending on small differences in substituent pattern.Identification of AM12 as a synthetic flavonol
that inhibits Ca2+ entry evoked by Gd3+
To further investigate structure–activity relationships ofﬂavonols,
a library of 41 mono-substituted ﬂavonols was synthesized using
a two-step procedure (Scheme S1) and screened at a
concentrationof 10μMagainstGd3+-evokedCa2+ entry inTRPC5
overexpressing HEK 293 cells (Figure S1). Guided by the results
with natural and synthetic ﬂavonols (Figure 4A and B), we
designed AM12 (Figure 4c), which was synthesized in four steps
(Scheme S2). AM12 inhibited the Gd3+-evoked Ca2+ signal with
an IC50 of 0.28 μM (Figure 4D and E). The data suggest thatFigure 3
Negative or positive modulation of TRPC5 by natural ﬂavonols. Recordings
Ca2+ was measured using XRhod-1. (A) Concentration–response data for
data for quercetin (IC50 6.5 μM, n/N = 5/25). (C–E) Whole-cell data o
every 10 s. (C) Example single-cell recording showing responses
2-aminoethoxydiphenylborate (2-APB) alone. (D) Example I-Vs for the
application of apigenin]. (E) Mean current amplitudes for experiments of tAM12 is slightly more potent than the natural product galangin
as an inhibitor of the Gd3+-evoked signal.
AM12 inhibits TRPC1/4/5 channels relatively
directly
To investigate if AM12 might directly inhibit TRPC5, we used
outside-out patch recordings and bath-applied AM12 to the
extracellular face of the membrane. Moreover, to address
the possibility that the effect of AM12 might be speciﬁc to
Gd3+-activated channel activity, we used an alternative, newly
described, TRPC5 activator, ()-Englerin A (Akbulut et al.,
2015). ()-Englerin A is considerably more potent and
efﬁcacious than Gd3+ (Figure 5A cf. Figure 1F). AM12 caused
prompt inhibition of ()-Englerin A-activated TRPC5 activity,
and there was fast recovery on washout (Figure 5A–C). The
average inhibition was ~65% at 5 μM AM12. AM12 also
inhibited current through TRPC1–TRPC5 heteromeric
channels, which were studied in whole-cell recordings because
of difﬁculty in obtaining outside-out patches from TRPC1-
expressing cells (Figure 5D-F). HEK 293 cells were transiently
transfected with SYFP2–TRPC1 and mTurquoise2–TRPC5, and
the expression of both proteins was detected by ﬂuorescence
microscopy. In whole-cell patches of cells overexpressing both
proteins and stimulated with ()-Englerin A, the characteristic
seat-like inﬂection of the TRPC5 I-V was missing (Figure 5E cf.
Figure 5B), which was consistent with the presence of
heteromeric TRPC1–TRPC5 channels (Akbulut et al., 2015).
AM12 was notably less effective against these heteromeric
channels, giving only ~20% inhibition at 5 μM (Figure 5D-F).were from TRPC5-expressing (Tet+) HEK 293 cells (A, B). Intracellular
kaempferol (IC50 3.9 μM, n/N = 5/22). (B) Concentration–response
btained from ramp changes in voltage from 100 to +100 mV
to 10 μM apigenin and 30 μM Gd3+ and then 75 μM
experiment in (C) [vehicle (veh.) indicates current before the
he type shown in (C) (n = 5 each). *P < 0.05.
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Figure 4
Design of AM12 and its inhibition of Gd3+-evoked TRPC5 activity. (A–C) Structure–activity relationships (SARs) of natural ﬂavonoids (A)
and synthetic, mono-substituted ﬂavonols (B). Comparison of natural ﬂavonoids with compound 4-A0 reveals the inﬂuence of hydroxyl
substituents on inhibitor potency. Comparison of compound series 4 (Figure S3) reveals that most TRPC5 inhibitors in this series
(inhibition >50% at 10 μM) had an ortho-substituted (R2) phenyl ring, while compounds with R1, R3 or R4 substituents had weak or
variable stimulatory effects. (C) Flavonol AM12 combines the hydroxylation pattern of galangin, the strongest natural TRPC5 inhibitor
found to date, with an ortho-substituted phenyl ring. The structure of AM12 is drawn as a twisted conformer to highlight the proposed
effect of an ortho-Br substituent. (D, E) Intracellular Ca2+ was measured using fura-2 in TRPC5-expressing (Tet+) HEK 293. (D) Example
data from a single 96-well plate showing basal Ca2+ and then Gd3+-evoked Ca2+ entry in the presence of vehicle (veh.) and 0.1, 1, 3
and 10 μM AM12. (E) Summarized concentration–response data for experiments of the type shown in (D) for Gd3+-evoked Ca2+ entry
(IC50 0.28 μM, n/N = 5/30).
BJP J Naylor et al.Outside-out patch recordings were also made from cells overex-
pressing TRPC4 homomeric channels, which are the most
closely related to TRPC5 channels (Figure 5G–I). As with TRPC5
homomers, AM12 promptly inhibited TRPC4, and the average
inhibition by 5 μMAM12was ~80% (Figure 5G–I). The data sug-
gest that AM12 inhibits TRPC5 and TRPC4 channels via a site
accessible from the extracellular face of the membrane, acting
directly on either the channel or a site closely associated with
it. AM12 has an effect on heteromeric TRPC1–TRPC5 channels,
but it is a relatively weak effect.Selectivity of AM12
At 10 μM, AM12 had a modest inhibitory effect on Ca2+ entry
through TRPC3 channels in some recordings, but overall, the
effect did not reach statistical signiﬁcance (Figure 6A). There
was a signiﬁcant stimulatory effect on Ca2+ entry through
TRPV4 channels, but no effect on TRPM2 channels
(Figure 6A–C). AM12 had no effect on the endogenous Ca2+
release signal evoked by thapsigargin or ATP (Figure 6D
and E). Thapsigargin causes Ca2+ release by inhibiting the
smooth endoplasmic reticular Ca2+ ATPase, whereas AT P
causes release via a GPCR and inositol 1,4,5-trisphosphate
production, via PLC activity. The data suggest AM12 has a568 British Journal of Pharmacology (2016) 173 562–574degree of selectivity for TRPC5 and TRPC4 channels but is
not completely speciﬁc.Stimulatory effect of AM12
Gd3+ and ()-Englerin A are not endogenous stimulators of
TRPC5. Therefore, we next investigated the effect of AM12
against TRPC5 activity evoked by the physiological substance
S1P. Unexpectedly, 10 μM AM12 stimulated rather than
inhibited S1P-evoked Ca2+ entry in HEK 293 cells over-
expressing TRPC5 (Figure 7A). Similarly, TRPC5-mediated
Ca2+ entry evoked by the endogenous substance LPC was
enhanced by AM12 (10 μM) (Figure 7B). In control cells
without induction of TRPC5 expression (Tet cells), there
were no effects of AM12 (Figure 7C), but to further
investigate if there were effects of AM12 in Tet- cells, we
investigated the effect of ATP in the presence of extracellular
Ca2+ and in the presence or absence of AM12 (Figure 7D).
AM12 had no effect on ATP- evoked Ca2+ release (Figure 6E)
but enhanced the AT P response in the presence of Ca2+
(Figure 7D). The data suggest that AM12 had a stimulatory
effect on an endogenous Ca2+ entry mechanism. Stimulation
of endogenous Ca2+ entry could potentially explain the
stimulatory effects of AM12 in Tet+ cells (Figure 7A and B)
Figure 5
Inhibitory effect of AM12 on TRPC1/4/5 channels stimulated by ()-Englerin A (EA). Recordings were made from outside-out membrane
patches from TRPC5 Tet+ cells (A–C) or TRPC4 Tet+ cells (G–I) or from whole-cell expressing SYFP2–TRPC1 and mTurquoise2–TRPC5 (D–F).
(A) Example TRPC5 outside-out patch currents during ramp changes in voltage from 100 to +100 mV every 10 s and application of
100 nM ()-EA and 5 μM AM12. (B) Example I-Vs for the experiment in (A). (C) Mean normalized data for TRPC5 outside-out patch currents
evoked by 100 nM ()-EA and 5 μM AM12 (n = 5). (D) Example TRPC1–TRPC5 whole-cell currents obtained during ramp changes in voltage
from 100 to +100 mV every 10 s and during application of 100 nM ()-EA and 5 μM AM12. (E) Example I-Vs for the experiment in (D).
(F) Mean normalized data for TRPC1–TRPC5 whole-cell currents evoked by 100 nM ()-EA and 5 μM AM12 (n = 5). (G) Example TRPC4
outside-out patch currents during ramp changes in voltage from 100 to +100 mV every 10 s and application of 100 nM ()-EA and 5 μM
AM12. (H) Example I-Vs for the experiment in (G). (I) Mean normalized data for TRPC4 outside-out patch currents evoked by 100 nM ()-EA
and 5 μM AM12 (n = 5). *P < 0.05.
Natural and synthetic ﬂavonoid modulation of TRPC5 channels BJPbecause Ca2+-mediated facilitation of TRPC5 channels has
been described previously in these Tet+ cells (Hui et al.,
2006). Nevertheless, it remained perplexing why AM12
did not act as an inhibitor when S1P and LPC were the
agonists.Discussion and conclusions
Through a screen of a small number of natural products from
traditional Chinese medicines, we found that the ﬂavonol
galangin is an inhibitor of lanthanide-evoked activity of TRPC5
channels overexpressed in HEK 293 cells (IC50 0.45 μM against
TRPC5-mediated Ca2+ entry). Galangin also inhibited Ca2+
entry through endogenous TRPC5-containing channels as
shown by studies of differentiated 3T3-L1 cells, although it
was 5–15 times less potent in these cells. Related natural
ﬂavonols were investigated, and two, kaempferol and
quercetin, were also inhibitors of overexpressed TRPC5 but
with less potency than galangin. Myricetin and luteolin lacked
effect. Apigenin had the reverse effect, stimulating TRPC5.Investigation of a panel of mono-substituted ﬂavonols led to
the design of compound AM12, which inhibited lanthanide-
evoked TRPC5 activity with an IC50 of 0.28 μM and showed a
degree of selectivity as demonstrated by no signiﬁcant inhibi-
tory effects at 10 μM on Ca2+ release or Ca2+ entry mediated
by TRPC3, TRPV4 or TRPM2 channels. However, unlike
galangin, AM12 potentiated TRPC5 activity evoked by the
physiological TRPC5 stimulators S1P and LPC, apparently
lacking inhibitory effect in this situation. The data suggest
complex modulator effects of natural and synthetic ﬂavonoids
on TRPC5 channels.
The modulator effects of natural ﬂavonoids depended on
variations in hydroxylation pattern, with inhibition being
more prominent in the ﬂavonols compared with the ﬂavones
(X = OH vs. H) (Table 1; Figure 4A). The inhibitory potency of
natural ﬂavonols decreased with increasing hydroxylation of
the phenyl ring (Table 1; Figure 4A, Z = OH), and within this
series, increased hydrophobicity (higher cLogP) seems to
correlate with higher potency (Table 1). To investigate
structure–activity relationships of ﬂavonols as TRPC5British Journal of Pharmacology (2016) 173 562–574 569
Figure 6
AM12 effects on TRPC3 channels, TRPV4 channels, TRPM2 channels and Ca2+ release. Intracellular Ca2+ was measured using ﬂuo-4 (B) or fura-2
(A, C, D, E). (a) Cells were stably overexpressing TRPC3 and the TRPC3 agonist 1-oleoyl-2-acetyl glycerol (OAG, 50 μM) was used to activate the
channels in the presence of the vehicle control (veh.) or 10 μMAM12. On the left are example data from a single 96-well plate and on the right are
mean data at two different time points for multiple plates of this type (n/N = 5/26). (B) Cells were stably overexpressing TRPV4 and the TRPV4
agonist 4α-phorbol 12,13-didecanoate (4αPDD, 1 μM) was used to activate the channels in the presence of the veh. or 10 μM AM12. On the left
are example data from a single 96-well plate, and on the right are mean data for multiple plates of this type (n/N = 5/35). (C) Cells were over-
expressing TRPM2, and the TRPM2 activator H2O2 (1 mM) was used to activate the channels in the presence of the veh. or 10 μM AM12. On the left
are example data from a single 96-well plate, and on the right are mean data for multiple plates of this type (n/N = 5/24). (D) Cells were non-induced
(Tet) TRPC5 HEK cells in the absence of extracellular Ca2+. Thapsigargin (TG, 3 μM) was applied to release intracellular Ca2+ in the presence of the
veh. or 10 μM AM12. On the left are example data from a single 96-well plate, and on the right are mean data for multiple plates of this type
(n/N = 5/32). (E) Cells were non-induced (Tet) TRPC5 HEK cells in the absence of extracellular Ca2+. A TP (100 μM) was applied to release
intracellular Ca2+ in the presence of the veh. or 10 μM AM12. On the left are example data from a single 96-well plate, and on the right are mean
data for multiple plates of this type (n/N = 5/25). *P < 0.05; NS, not signiﬁcant; AU, arbitrary unit.
BJP J Naylor et al.modulators, we made and tested a panel of mono-substituted
ﬂavonols (Supporting Information). Most of the compounds
had weak or variable stimulatory effects, and so, we focused
on inhibition (Figure 4B). Most compounds that caused
>50% inhibition contained ortho-substituted phenyl rings
(Figure S3 and Figure 4B, R2 = OH, CH3, F, Cl or Br), whilemost
compounds with R1, R3 and R4 substituents (Figure 4B
and Figure S3) had weak or mixed effects. For the mono-
substituted ﬂavonols, no correlation between hydrophobic-
ity and potency could be detected.
The pronounced effect of ortho-substituents (R2) as compared
with meta-substituents (R3) and para-substituents (R4) on the
ﬂavonol phenyl ring might be attributed to their inﬂuence on
the dihedral angle between the chromone and phenyl rings
of the ﬂavonol scaffold. Ortho-substituents may cause restrictions
on the conformational freedom of such biaryl scaffolds,570 British Journal of Pharmacology (2016) 173 562–574favouring non-planar conformers. Therefore, if TRPC5 inhibition
is favoured by twisted ﬂavonol conformers, ortho-substituents
may offer an energetic advantage by providing a conformational
lock. To test this hypothesis, we designed and synthesized AM12
(Figure 4C), a galangin analogue with an ortho-bromine
substituent on the phenyl ring (see the Supporting Information
for synthesis). AM12 was slightly more potent than galangin as
an inhibitor of Gd3+-evoked activity (Figure 4E cf. Figure 1B),
which could be attributed to restriction of conformational
freedom, but also ﬁts the tentative correlation between
hydrophobicity and potency as observed for natural ﬂavonols
(Table 1). However, the surprising stimulatory effect (Figure 7)
and the more rapid reversibility of the inhibitory effect (Figure 5)
suggested that subtle changes of ﬂavonol substituents have a
major impact on activity, mode of action and/or interaction
with other calcium responses in the cell.
Figure 7
Stimulatory effects of AM12 on TRPC5. Intracellular Ca2+ was measured using fura-2, and recordings were from TRPC5-expressing (Tet+)
HEK cells or control non-induced (Tet) cells. (A) Example data from Tet+ cells in a single 96-well plate showing the response to 5 μM S1P
in the presence of vehicle control (veh.) or 10 μM AM12 (left) and mean data for multiple plates of this type (n/N = 7/40). (B) Example data
from Tet+ cells in a single 96-well plate showing the response to 10 μM LPC in the presence of veh. or 10 μM AM12 (left) and mean data for
multiple plates of this type (n/N = 9/56). (C) Mean data for the type of experiments shown in (A) (left; n/N = 6/31) and (B) (right; n/N = 5/20)
for Tet cells. (D) Example data from Tet cells in a single 96-well plate showing the response to 100 μM ATP in the presence of veh. or 10 μM
AM12 (left) and mean data for multiple plates of this type (right; n/N = 5/30). *P < 0.05; NS, not signiﬁcant.
Natural and synthetic ﬂavonoid modulation of TRPC5 channels BJPBased on simulations of molecular dynamics and func-
tional membrane protein assays, it has been hypothesized
that amphiphilic polyphenol phytochemicals – including
the polyphenol resveratrol – localize to the membrane/
solution interface, thereby reducing the energy required for
bilayer adaptations perpendicular to the plane of the bilayer
(Ingolfsson et al., 2014). Such an effect could alter conforma-
tional equilibria of membrane proteins whose function de-
pends on conformational changes that are associated with
bilayer perturbations. Quercetin and its metabolites have also
been proposed to localize to the membrane/solution inter-
face, enhancing their local concentrations and thereby their
antioxidant effect on nearby lipids and membrane proteins
(Kosinova et al., 2012). In addition, membrane penetration,
and therefore local antioxidant effect, of quercetin deriva-
tives was predicted to correlate with polarity of substituents
(Kosinova et al., 2012). TRPC5 channels are susceptible to per-
turbations of the lipid bilayer as suggested by effects on chan-
nel activity of lipids depending on chain length and general
anesthetics (Bahnasi et al., 2008; Flemming et al., 2006).
Therefore, a plausible mechanism of action for ﬂavonoids
on TRPC5 is local perturbation of the bilayer, which then
modulates channel activity.
The ﬂavonols tested in this study all have a predicted
pKa1 (ﬁrst deprotonation) of ~6.4, which means that at
physiological pH, their amphiphilic mono-anions are the
most prevalent species (Figure S4). In addition, the predicted
octanol/water partition coefﬁcients (cLogP) of galangin and
AM12 (2.76 and 3.53 respectively) are in the same range as
those of other polyphenol phytochemicals predicted tolocalize to the membrane/solution interface (Ingolfsson
et al., 2014), and the apparent correlation between hydro-
phobicity within a subset of TRPC5-inhibiting ﬂavonols –
but not ﬂavones – (Table 1) is consistent with localization
of the (substituted) phenyl ring of these compounds to a
hydrophobic environment. However, the observation that
subtle changes of ﬂavonol substituent patterns can turn a
poorly reversible inhibitor into a readily reversible inhibitor
(galangin cf. AM12) and a TRPC5 inhibitor into a TRPC5
activator (galangin cf. apigenin) suggests that the mecha-
nism of action of ﬂavonols is more complex: activities may
depend on membrane afﬁnity, membrane localization and
perturbation, and redox potential. In addition, distinct
TRPC5 binding sites and/or ﬂavonoid-mediated modulation
of calcium responses (including calcium release) through
other proteins cannot be excluded. Moreover, the discovery
of inhibitory and stimulatory effects of AM12 suggests a
combination of effects.
Apigenin activated TRPC5, and it has previously been
reported as a TRP activator, stimulating TRPV4 channels
(Ma et al., 2012). A related isoﬂavone genistein also
stimulated TRPC5 (Wong et al., 2010). Genistein has effects
consistent with perturbation of the lipid bilayer (Ingolfsson
et al., 2014).
The failure of AM12 to inhibit S1P-evoked or LPC-evoked
TRPC5 activity is perplexing. It appears to be the case
that AM12 had a separate stimulatory effect on another
Ca2+ entry mechanism, which might then have facilitated
TRPC5 activity. Nevertheless, despite such a possibility for
facilitation, Gd3+-evoked TRPC5 activity was inhibited byBritish Journal of Pharmacology (2016) 173 562–574 571
Table 1
Relationships between substituent pattern, hydrophobicity and
potency of natural ﬂavonoids and AM12a
Compound
name
Compound structure IC50 (μM) cLogP
b
AM12c 0.28 3.53
Galangin 0.45 2.76
Kaempferol 3.9 2.46
Quercetin 6.5 2.16
Myricetin >>10 1.85
Apigenind >>10 2.71
Luteolin >>10 2.40
aTRPC5 inhibition was measured in TRPC5‐expressing (Tet+) HEK
293 cells treated with ethanolic solutions of ﬂavonoids (10 mM
stock solutions). TRPC5 was stimulated with 50 μMGd3+, and Ca2+
entry wasmeasured using the calcium‐reactive dye ﬂuo‐4 unless stated
otherwise. The positive controls consisted of HEK 293 cells overex-
pressing TRPC5 and stimulated with 50 μMGd3+, treated with vehicle
(ethanol) only. The negative controls consisted of recordings from
(Tet−) cells, which do not overexpress TRPC5.
bcLogPs were calculated using chemicalize.org; ChemAxon: http://
www.chemaxon.com; accessed October 2015.
cThe calcium‐reactive dye fura‐2 was used in experiments with
AM12.
dApigenin acted as a stimulator of TRPC5 instead (Figure 3C–E).
BJP J Naylor et al.AM12, whereas S1P-evoked and LPC-evoked activities were
not. These observations suggest that AM12 is not a direct
inhibitor of the TRPC5 ion pore but a modulator that572 British Journal of Pharmacology (2016) 173 562–574allosterically affects TRPC5 gating or the ion pore – by
binding to TRPC5 or by perturbing the plasma membrane
around TRPC5-containing channels, or by acting more in-
directly via a molecule closely associated with TRPC5. The
data suggest the possibility for differential modulation of
TRPC5 depending on its activation state; for example, it
seems possible to inhibit lanthanide-evoked and constitu-
tive channel activity without affecting lipid-evoked activity.
We suspect that this complication is also involved in
()-Englerin A-evoked activity. Although 5 μM AM12
inhibited ()-Englerin A-evoked TRPC5 activity, the effect
was on average less than that observed against Gd3+-evoked
activity, and in some recordings, the effect against
()-Englerin A-evoked activity was surprisingly small,
suggesting that a mixture of inhibitory and stimulatory
actions of AM12 can affect the ()-Englerin A response.
The suppressive effect of galangin on lanthanum-evoked
Ca2+ entry in differentiated 3T3-L1 cells suggests that it in-
hibits native TRPC5-containing channels, which include
other TRPC proteins such as TRPC1 (Sukumar et al., 2012).
Consistent with the weaker effect of galangin on native chan-
nels (as compared with TRPC5 homomers), 5 μM AM12 had a
small inhibitory effect on TRPC1–TRPC5 heteromeric chan-
nels (Figure 5D–F). Activity of galangin and other ﬂavonoids
in adipocytes has been previously reported. Ethanolic
A. officinarum extract has been reported to inhibit adipocyte
differentiation and high-fat diet-induced obesity in mice,
and galangin (its major component), and had anti-adipogenic
effects in 3T3-L1 cells (Jung et al., 2012). Genistein inhibited
proliferation and subsequent differentiation of 3T3-L1 cells
(Harmon and Harp, 2001). Quercetin inhibited 3T3-L1 cell
growth and apoptosis (Hsu and Yen, 2006). TRPC5-
containing endogenous channels were up-regulated in
differentiated 3T3-L1 cells, and inhibition of channel func-
tion in vivo by a dominant-negative mutant TRPC5 raised
circulating adiponectin levels, which is expected to have a
cardioprotective effect (Sukumar et al., 2012). Therefore,
ﬂavonoids may act as natural regulators of adipocyte
biology at least in part via modulation of Ca2+ entry
through TRPC5-containing channels, conferring a mecha-
nism for integration with the environment via dietary in-
take. It should be noted, however, that ﬂavonoids are not
speciﬁc for TRPC5 channels. Galangin inhibited Cav1.2
channels in smooth muscle, while quercetin, myricetin
and kaempferol were stimulators (Saponara et al., 2011).
Kaempferol and quercetin stimulated BKCa channels
(Cogolludo et al., 2007; Xu et al., 2008b). Apigenin and
quercetin inhibited GABA-evoked ionic currents (Goutman
et al., 2003).
In summary, the study suggests that naturally occurring
ﬂavonoids can modulate TRPC5 channels and that one
consequence in vivo might be modulation of adiponectin
secretion. The effects of synthetic ﬂavonols on TRPC5
activity show that potency and mode of action of ﬂavonols
on TRPC5 channels can be tuned by subtle changes of
substituent patterns and suggest future directions for the
development of more potent ﬂavonol-based TRPC5 inhibitors.
Nevertheless, effects of ﬂavonols are difﬁcult to predict,
and their numerous biological activities render them
potentially problematic for drug discovery efforts (Baell and
Walters, 2014).
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Figure S1 Overview of chemicals from traditional Chinese
medicines screened against Ca2+entry in HEK 293 cells over-
expressing human TRPC5.
Figure S2 Screen of natural ﬂavonols against Ca2+ entry in
HEK 293 cells over-expressing human TRPC5. Intracellular
Ca2+ was measured using XRhod-1. Mean data comparing re-
sponses to 50 μM Gd3+ in the presence of 10 μM galangin,
kaempferol, quercetin, myricetin,apigenin, luteolin or vehi-
cle control (veh.) (n/N=3/12 each). Data were normalized to
the Gd3+ response in vehicle and Tet+ cells.
Figure S3Overview of synthetic mono-substituted ﬂavonols
that were screened for TRPC5 inhibition at 10 μM. Com-
pounds that inhibited Gd3+-evoked calcium entry in TRPC5-
expressing HEK293 cells by > 50% are highlighted in red.
Figure S4 pKa1 values and structures of major microspecies
(mm) of tested natural ﬂavonoids and AM12 (predicted using
Marvin Beans; downloaded from ChemAxon: http://www.
chemaxon.com).
Scheme S1 General synthetic route towards a library of
mono-substituted ﬂavonols 4. Aldol condensation of
2-hydroxyacetophenones 1 with benzaldehydes 2 was
followed by oxidative cyclisation of the intermediate
chalcones 3 by use of an Algar-Flynn-Oyamada reaction.
Scheme S2 Synthesis of synthetic ﬂavonol AM12. Benzoic
anhydride 6 was prepared from its corresponding benzoic
acid 5. Friedel-Crafts acylation of phloroglucinol with acyl
chloride 8 gave intermediate 9. Combination of building
blocks 6 and 9 in an Allan-Robinson reaction followed by
boron tribromide-mediated demethylation afforded AM12.
THF: tetrahydrofuran.
